Vildagliptin Completed Phase 4 Trials for 1- Microvascular Function / 3-inflammation / 2-oxidative Stress Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01827280Acute and Short-term Chronic Effects of Galvus (Vildagliptin) in Diabetes Type 2 Obese Women